LEADER 01393nam  2200457   450 
001 9910827771803321
005 20230807211117.0
010   $a1-910419-93-1
010   $a1-910419-92-3
035   $a(CKB)3440000000001031
035   $a(MiAaPQ)EBC5092547
035   $a(Au-PeEL)EBL5092547
035   $a(CaPaEBR)ebr11451432
035   $a(OCoLC)953863761
035   $a(EXLCZ)993440000000001031
100   $a20171109h20152015  uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 00$aAdvances and challenges in the delivery of nucleic acid therapeutics$hVolume 1 /$feditors, Olivia Merkel, Mansoor Amiji
210  1$aLondon, England :$cFuture Science Ltd,$d2015.
210  4$dİ2015
215   $a1 online resource (136 pages) $cillustrations (some color)
311   $a1-910419-94-X 
320   $aIncludes bibliographical references.
606   $aAntisense nucleic acids
606   $aNucleic acids
615  0$aAntisense nucleic acids.
615  0$aNucleic acids.
676   $a572.8
702   $aMerkel$b Olivia
702   $aAmiji$b Mansoor
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910827771803321
996   $aAdvances and challenges in the delivery of nucleic acid therapeutics$94049199
997   $aUNINA